Which weight-loss method is effective?

No single method is right for everyone. While bariatric surgery can achieve high loss at 25–35% TBWL, the Allurion gastric balloon (14.9% TBWL) stands out for medication-free long-term maintenance: in clinical follow-up, approximately 95% of patients maintained their result at year 1 (PMID: 32279182, PMID: 40676353). The right choice is determined in a physician's evaluation based on your BMI, health status, and lifestyle.

How effective are GLP-1 medications for weight loss?

GLP-1 receptor agonists can provide an average of 12–15% TBWL; however, after the medication is stopped, an average of +5.63 kg is regained (18 RCTs, 3,771 patients, PMID: 41399474). The effect depends on the medication and requires ongoing use. Individual results may vary.

How much weight does the Allurion gastric balloon help you lose?

The Allurion gastric balloon, which provides an average of 14.9% TBWL, has the effectiveness reported in the Obes Surg 2020 study covering 1,770 patients (PMID: 32279182). Throughout the 16-week balloon process, the accompanying digital behavioral program (App, Scale, VCS) aims to restructure eating habits. Individual results may vary.

Is the Allurion balloon FDA-approved?

Yes, the Allurion swallowable gastric balloon was approved by the FDA as PMA Class III on 23 February 2026. This is the strictest approval class.

Can the weight be maintained after losing it with the gastric balloon?

Yes, in clinical follow-up data the large majority of patients (approximately 95%) were able to maintain the weight lost at year 1 after the Allurion program (PMID: 40676353). The accompanying digital behavioral program contributes to this weight maintenance. Individual results may vary.

Which weight-loss method is right for me?

For those with a BMI of 27–35 who do not want anesthesia, the Allurion gastric balloon; for those with BMI ≥ 30, GLP-1 medications or Allurion may be considered; for BMI ≥ 40, bariatric surgery is the priority. The final decision should be made in an evaluation by a specialist physician.

Which Weight-Loss Method Is Right for Whom? An Evidence-Based 2026 Comparison Guide

A web search for the "most effective weight-loss method" returns millions of results — but most are either advertising or lack clinical data. In this article, we compare the proven methods as of 2026 using real numbers.

Short answer: The most effective method is the one that's right for you. Suitability and sustainability — not raw numbers — determine it.

What Does "Effective" Mean?

In weight-loss research there are two distinct dimensions of effectiveness:

Short-term effectiveness: How much weight did you lose during the program?
Long-term effectiveness: How much did you maintain after 1–2 years?

The second is far more important. "Losing quickly and gaining it back" is not the intended outcome.

Method 1: Lifestyle Change

What it involves: Calorie restriction + exercise + behavioral coaching

Short-term effectiveness: 5–10% TBWL in intensive programs Long-term effectiveness: Without structural support, most of the loss is regained after 2 years

Who it suits: BMI 25–30, with strong motivation and a support structure Cost: Low Risk: Almost zero

It is a mandatory complement to all other methods.

Method 2: GLP-1 Receptor Agonists

What it involves: Hormonal appetite-regulating medications (injectable or oral)

Short-term effectiveness: Average 12–15% TBWL (more at higher doses) Long-term effectiveness (after stopping the medication): Average +5.63 kg regain
→ 18 RCTs, 3,771 patients, EClinicalMedicine 2025 PMID: 41399474

Who it suits: BMI ≥ 30, or ≥ 27 + metabolic comorbidity Cost: High (ongoing monthly) Risk: Nausea, vomiting, constipation; rare pancreatitis

Critical note: The effect depends on the medication. If it is stopped, weight largely returns.

Method 3: Allurion Swallowable Gastric Balloon

What it involves: A 16-week swallowable balloon + digital program (App + Scale + VCS)

Short-term effectiveness: Average 14.9% TBWL
→ 1,770 patients, Obes Surg 2020 PMID: 32279182

Long-term effectiveness: In clinical follow-up data, the large majority of patients (approximately 95%) were able to maintain the weight lost at year 1 after the program; individual results may vary.
→ Caballero et al., 522 patients, weight-maintenance analysis, Obes Surg 2025 PMID: 40676353

Who it suits: BMI 27–40, those who do not want anesthesia/surgery Cost: One-time Risk: Serious adverse events <0.2%; nausea expected in the first week

The differentiator: The digital behavioral program (App, Scale, VCS) that accompanies the 16-week balloon period aims to restructure nutrition and activity habits; the contribution of this structural support to weight maintenance has been observed in clinical follow-up data (PMID: 40676353).

Real-world data also support this: Multicenter 2025, PMID: 41037243

Method 4: Bariatric Surgery

Subtypes: Sleeve gastrectomy, Roux-en-Y bypass, mini bypass

Short- and long-term effectiveness: 25–35% TBWL, with 10-year follow-up data available Who it suits: BMI ≥ 35 + comorbidity, or ≥ 40 Cost: High (one-time) Risk: General anesthesia, surgical complications (<3% serious), permanent anatomical change

Lifelong: Vitamin and mineral supplementation, dietary restrictions

Combination: A Next-Generation Approach

The combined use of a GLP-1 receptor agonist with the Allurion Balloon is under investigation in patients selected by physician evaluation. Preliminary findings point to the potential for significant total body weight loss with the combination approach; the data are still maturing and final conclusions must be confirmed by peer-reviewed publication (for combination evidence, see PMID: 41212463). Individual results may vary, and use depends on the physician's decision.

Theoretical strength: GLP-1's hormonal effect + Allurion's behavioral program → GLP-1 can later be discontinued while the habits are retained.

Which Method Is Right for Whom?

Profile	Recommended Consideration
BMI 25–27, just starting out	Lifestyle change + dietitian
BMI 27–35, does not want anesthesia	Allurion gastric balloon
BMI ≥ 30, has diabetes/HT	GLP-1 RA or Allurion — decide with your physician
BMI 35–40, conservative approach failed	Allurion bridge → bariatric surgery
BMI ≥ 40	Bariatric surgery prioritized
Does not want long-term medication	Allurion or bariatric

The 2026 Reality: There Is No Single "Most Effective Method" — the Decision Is Individual

The clinical numbers show:

Highest weight loss: Bariatric surgery (25–35%)
Standout for medication-free long-term maintenance: Allurion — in clinical follow-up, approximately 95% of patients maintained their result at year 1 (PMID: 32279182, PMID: 40676353)
Marked early-phase appetite effect: GLP-1 RA (strong appetite suppression in the first weeks)
Lowest risk: Lifestyle change

But the answer to the question of the "most effective method" is individual: your BMI, your health status, your lifestyle, and your preferences shape this decision.

Individual results may vary. All treatment decisions should be made under the guidance of a specialist physician.

Continue reading:

This content is for general informational purposes based on clinical data. Personal treatment decisions should be made together with your specialist physician.

Find an Authorized Clinic in a City Near You

You can have the Allurion Program performed at more than 60 authorized clinics across Türkiye. For clinics in the major cities:

Clinical Sources

Obesity & Research

The Link Between Obesity and Type 2 Diabetes — The Gastric Balloon Effect

The relationship between obesity and type 2 diabetes, the effect of weight loss on HbA1c, and up-to-date information on the use of the Allurion Program in diabetic patients.

2026-03-137 min read

Obesity & Research

30 Questions About the Gastric Balloon: Comprehensive Answers and FAQ

The 30 most frequently asked questions about the gastric balloon, with answers based on clinical data. Everything about the procedure, safety, nutrition, pricing, and results.

2026-03-1214 min read

Obesity & Research